Stock listing

NASDAQ:KITE Kite Pharma Inc Stock

Follow Kite Pharma Inc into a list and get an email when it puts out news.

Last close · NASDAQ:KITE

$179.79 USD

Close on Oct 3, 2017 · No longer trades

Jun 20, 2014 to last close +520.0% · weekly closes, Jun 20, 2014 – Oct 3, 2017
Lowest – highest close
$21.39 – $179.81 USDSince Jun 20, 2014 · lowest Jul 16, 2014 · highest Sep 29, 2017

Delisted NASDAQ:KITE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:KITE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ian T. Clark
Other companies: Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); BioMarin Pharmaceutical Inc. (Chair of the Board, · Since at least Aug 1, 2025); GoodRx Holdings, Inc. (Director · Since at least Jul 8, 2024); Kyverna Therapeutics, Inc. (Independent Director · Since at least Feb 7, 2024); Olema Pharmaceuticals, Inc. (Director · Since at least Aug 12, 2020); Guardant Health, Inc. (Director · Since at least Oct 3, 2018); Corvus Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2017); Forty Seven Inc (Director · Jun 27, 2018 – Apr 7, 2020 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 6, 2023 · Past); Agios Pharmaceuticals, Inc. (Director · Dec 30, 2016 – May 20, 2022 · Past); Terravia Holdings Inc (Director · May 26, 2011 – May 22, 2017 · Past); Dendreon Corp (Director · Oct 7, 2009 – Aug 20, 2010 · Past); Genentech Inc (EVP-COMMERCIAL · Sep 20, 2006 – Mar 26, 2009 · Past)
Director · Jan 3, 2017 – Oct 3, 2017 · Past
Cynthia M. Butitta
Other companies: Autolus Therapeutics plc (Chair of the Compensation Committee, Member of the Audit Committee · Since at least Mar 18, 2026); Century Therapeutics, Inc. (Director · Since at least Jun 17, 2021); Olema Pharmaceuticals, Inc. (Director · Since at least Aug 12, 2020); UroGen Pharma Ltd. (of the Audit Committee · Since at least Jan 1, 2019)
Chief Operating Officer · Jun 19, 2014 – Oct 3, 2017 · Past
Farah Champsi
Other companies: Population Health Investment Co Inc (Director · Nov 17, 2020 – Jan 26, 2021 · Past); Trevena, Inc. (Director · Jan 30, 2014 – Dec 10, 2014 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – May 28, 2013 · Past); Chimerix Inc (Director · Apr 10, 2013 – Oct 23, 2013 · Past)
Director · Jun 19, 2014 – Oct 3, 2017 · Past
Timothy L Moore
Other companies: BioLife Solutions, Inc. (Director · Since at least Sep 1, 2022); Cerus Corporation (Director · Since at least Sep 5, 2018); Allogene Therapeutics, Inc. (Chief Technical Officer · Apr 24, 2023 – Feb 3, 2025 · Past); Instil Bio, Inc. (Chief Operating Officer · Sep 6, 2022 – Sep 6, 2022 · Past)
EVP, Technical Operations · Mar 15, 2016 – Oct 3, 2017 · Past
Jonathan M Peacock
Other companies: Avantor, Inc. (Director · May 16, 2019 – May 8, 2025 · Past); Bellerophon Therapeutics Inc (Director · Feb 13, 2015 – Mar 31, 2021 · Past); Amgen Inc. (EVP & CFO · Apr 25, 2013 – Oct 28, 2013 · Past)
Director · Jun 19, 2014 – Oct 3, 2017 · Past
David Chang
Other companies: Allogene Therapeutics, Inc. (Co-Founder · Since at least Oct 10, 2018)
EVP, R&D, Chief Medical Off. · Jun 19, 2014 – Oct 3, 2017 · Past
Jeffrey WiezorekSVP Clinical Development · Jul 15, 2015 – Oct 3, 2017 · Past
Marc BetterVP, Product Sciences · Jun 19, 2014 – Feb 1, 2016 · Past
Paul L JenkinsonChief Financial Officer · May 16, 2016 – Oct 3, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Kite Pharma Inc.